Claims for Patent: 7,494,671

Summary for Patent: 7,494,671

Title:	Extract of Trapa natans and methods of using the same
Abstract:	The present invention provides extracts of Trapa natans L. useful for inhibiting, interfering and/or controlling pathological angiogenesis or neovascularization of tissues. The invention also provides a method to inhibit metastatis of cancer of colon, lung, liver, kidney, breast and/or cervix in a subject, comprising administering an effective amount of an extract of Trapa natans L. to the subject.
Inventor(s):	Wong; Kin-Ping (Fresno, CA), Wong; Ming-Chung (Fresno, CA)
Assignee:	Wong; Kin-Ping (Fresno, CA)
Application Number:	11/123,150
Patent Claims:	1. A method for inhibiting metastasis of cancer in a subject suffering from cancer, comprising administering a cancer metastasis inhibitory effective amount of a product comprising an extract from the shells of two-horned and four-horned fruits of Trapa natans L. to the subject, wherein the cancer is cancer of the colon, lung, liver, kidney, prostate, breast and/or cervix. 2. The method of claim 1, wherein the extract is prepared by exposing the shells of two-horned and four-horned fruits of Trapa natans L. to a polar organic solvent or aqueous medium. 3. The method of claim 2, wherein the extract is prepared by exposing the shells of two-horned and four-horned fruits of Trapa natans L. to a polar organic solvent. 4. The method of claim 3, wherein the polar organic solvent is an alcohol. 5. The method of claim 2, wherein the extract is prepared by exposing the shells of two-horned and four-horned fruits of Trapa natans L. to an aqueous medium. 6. A method for inhibiting metastasis of cancer in a subject suffering from cancer, comprising administering a cancer metastasis inhibitory effective amount of a product comprising an extract from the shells of two-horned and four-horned fruits of Trapa natans L. to the subject, the extract containing (a) no compounds having a molecular weight of about 170 to about 200, or (b) no gallic acid and/or alkoxylated or hydroxylated gallic acid, wherein the cancer is cancer of the colon, lung, liver, kidney, prostate, breast and/or cervix. 7. The method of claim 1, wherein the subject is in need of inhibition of metastasis of the cancer. 8. The method of claim 1, wherein the subject is a mammal. 9. The method of claim 8, wherein the mammal is a human. 10. The method of claim 9, wherein the mammal is a human patient. 11. The method of claim 8, wherein the subject is a mammalian pet. 12. The method of claim 11, wherein the mammalian pet is a cat or dog. 13. The method of claim 11, wherein the subject is a mammalian farm animal. 14. The method of claim 1, further comprising applying an anti-cancer therapeutic regimen to the subject. 15. The method of claim 14, wherein the anti-cancer therapeutic regimen comprises the administration of at least one anti-cancer chemotherapeutic agent to the subject. 16. The method of claim 15, wherein the at least one anti-cancer chemotherapeutic agent is selected from the group consisting of doxorubicin, daunorubicin, epirubicin, paclitaxel, docetaxel, 5-fluorouracil, cyclophosphamide, methotrexate, cisplatin, carboplatin,. vincristine, vinblastine, etoposide, tenoposide, bleomycin, plicamycin, mitomycin, mitotane, tamoxifen, letrozole, anastrozole, exemestane, vinorelbine, gemcitabine, capecitabine and Avastin. 17. The method of claim 15, wherein the anti-cancer therapeutic regimen comprises administering to the subject at least one therapeutic agent selected from the group consisting of interferon alpha, interferon beta, interferon gamma, interleukin-2, aldesleukin, filgrastim, sargramostim, levamisole, BCG vaccine, methotrexate, 5-fluorouracil, floxuridine, cytarabine, 5-azacytidine, mercaptopurine, thioguanine, pentastatin, fludarabine, cladribine, gemcitabine, mechiorethamine, chlorambucil, cyclophosphamide, melphalan, lomustine, carmustine, semustine, streptozocin, dacarbazine, busulfan, thiotepa, altretamine, ifosfamide, cisplatin, carboplatin, procarbazine, actinomycin D, plicamycin, bleomycin, doxorubicin, daunorubicin, idarubicin, mitoxanthrone, mitomycin, vincristine, vinbiastine, vinorelbine, etoposide, teniposide, paclitaxel, topotecan, asparaginase, hydroxyurea, mitotane, dexamethasone, aminoglutethimide, estradiol, diethyistilbestrol, hydroxyprogesterone, medroxyprogesterone, megestrol, testosterone, fluoxymesterone, tamoxifen, leuprolide and flutamide. 18. The method of claim 14, wherein the anti-cancer therapeutic regimen comprises the administration of anti-cancer radiation to the subject. 19. The method of claim 1, further comprising the application of surgery in the subject. 20. The method of claim 1, further comprising administering to the subject at least one anti-angiogenesis agent other than the extract from the shells of the two-horned and four-horned fruits of Trapa natans L. 21. The method of claim 20, wherein the at least one anti-angiogenesis agent other than the extract from the shells of two-horned and four horned fruits of Trapa natans L. is selected from the group consisting of Avastin, ammonium sulfate precipitate of shark cartilage, extracts of shark cartilage, Shimeji DEAB alpha, Shimeji Mono-Q alpha, 3-aminobenzamide, cisplatin, dalteparin, suramin, 2-methoxyestradiol, thalidomide, combretastain A4 phosphate, genistein, interferon-alpha, VEGF-Trap, celecoxib, halofuginone hydrobromide and interleukin-12. 22. The method of claim 21, wherein the at least one anti-angiogenesis agent other than the extract from the shells of the two-horned and four-horned fruits of Trapa natans L. is Avastin. 23. The method of claim 6, wherein the extract is prepared by exposing the shells of the two-horned and four-horned fruit of Trapa natans L. to an alcohol or aqueous medium. 24. The method of claim 6, further comprising applying an anti-cancer therapeutic regimen to the subject. 25. A method for inhibiting metastasis of cancer in a subject suffering from cancer, comprising administering a cancer metastasis inhibitory effective amount of a product consisting essentially of an extract from the shells of the two-horned and four-horned fruits of Trapa natans L. to the subject, wherein the cancer is cancer of the colon, lung, liver, kidney, prostate, breast and/or cervix. 26. The method of claim 25, wherein the extract is prepared by exposing the shells of the two-horned and four-horned fruits of Trapa natans L. to an alcohol or aqueous medium. 27. The method of claim 25, further comprising applying an anti-cancer therapeutic regimen to the subject.

Details for Patent 7,494,671

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2022-11-08
Merck Teknika Llc	N/A	bcg vaccine	For Injection	103050	06/21/1989		2022-11-08
Clinigen, Inc.	PROLEUKIN	aldesleukin	For Injection	103293	05/05/1992		2022-11-08
Amgen, Inc.	NEUPOGEN	filgrastim	Injection	103353	02/20/1991		2022-11-08
Amgen, Inc.	NEUPOGEN	filgrastim	Injection	103353	06/28/2000		2022-11-08
Partner Therapeutics, Inc.	LEUKINE	sargramostim	For Injection	103362	03/05/1991		2022-11-08